- The Oxford Stone Group Research Group
DPhil MSc MA FRCS (Urol) PGDipLATHE
- Clinical Lecturer in Urology
My current work is investigating the response of kidney cells to stone crystals and the metabolites in patients' urine that may influence stone formation.
I am a Clinical Lecturer in Urology with a joint contract between the University of Oxford and the Oxford University Hospitals Trusts. I have been instrumental in setting up the Oxford Stone Group in collaboration with the other research groups interested in Stone Disease in Oxford. In 2007 I was awarded an NIHR clinical lectureship, following my DPhil research.
For the last few years I have been been investigating the urinary proteins that may be involved in kidney stone formation. My recent work in this field has revealed some new proteins that may be involved in the process of stone formation.
Efficacy of the lithotripsy in treating lower pole renal stones.
Cui H. et al, (2013), Urolithiasis, 41, 231 - 234
Switching off micturition using deep brain stimulation at midbrain sites.
Green AL. et al, (2012), Ann Neurol, 72, 144 - 147
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG. et al, (2012), BJU Int, 110, 84 - 94
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: Results for 778 patients from a hospital haematuria clinic
Blick CGT. et al, (2012), BJU International, 110, 84 - 94
Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks.
Turney BW. et al, (2012), Radiother Oncol, 103, 402 - 409